COVID-19 and posterior reversible encephalopathy syndrome: A case report

The novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) caused an epidemic in December 2019 in Wuhan, China, which became a pandemic (as designated by the WHO), creating a current health emergency.1 A preliminary report warned that SARS-CoV-2 had neuroinvasive potential, as some infected patients had neurological symptoms such as headache, nausea, and vomiting.2 Several subsequent reports have described the emergence of various neurological disorders in the evolution of SARSCoV-2 infectious processes. In this article, we report the case of a patient with COVID-19 who presented with posterior reversible encephalopathy syndrome (PRES), diagnosed on clinical, laboratory, and imaging bases.